139 related articles for article (PubMed ID: 21348637)
1. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression.
Miceli V; Cocciadiferro L; Fregapane M; Zarcone M; Montalto G; Polito LM; Agostara B; Granata OM; Carruba G
OMICS; 2011 May; 15(5):313-7. PubMed ID: 21348637
[TBL] [Abstract][Full Text] [Related]
2. Merlin, the product of NF2 gene, is associated with aromatase expression and estrogen formation in human liver tissues and liver cancer cells.
Cocciadiferro L; Miceli V; Granata OM; Carruba G
J Steroid Biochem Mol Biol; 2017 Sep; 172():222-230. PubMed ID: 27289045
[TBL] [Abstract][Full Text] [Related]
3. Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells.
Miceli V; Cervello M; Azzolina A; Montalto G; Calabrò M; Carruba G
Ann N Y Acad Sci; 2009 Feb; 1155():252-6. PubMed ID: 19250212
[TBL] [Abstract][Full Text] [Related]
4. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells.
Castagnetta LA; Agostara B; Montalto G; Polito L; Campisi I; Saetta A; Itoh T; Yu B; Chen S; Carruba G
Cancer Res; 2003 Aug; 63(16):5041-5. PubMed ID: 12941832
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the fundamental properties of the N-terminal truncation (Δ exon 1) variant of estrogen receptor α in the rat.
Hattori Y; Ishii H; Morita A; Sakuma Y; Ozawa H
Gene; 2015 Oct; 571(1):117-25. PubMed ID: 26151894
[TBL] [Abstract][Full Text] [Related]
6. Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells.
Granata OM; Cocciadifero L; Campisi I; Miceli V; Montalto G; Polito LM; Agostara B; Carruba G
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):290-5. PubMed ID: 19429435
[TBL] [Abstract][Full Text] [Related]
7. Aromatase in nontumoral and malignant human liver tissues and cells.
Carruba G
Ann N Y Acad Sci; 2009 Feb; 1155():187-93. PubMed ID: 19250204
[TBL] [Abstract][Full Text] [Related]
8. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
9. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma.
Lin YM; Velmurugan BK; Yeh YL; Tu CC; Ho TJ; Lai TY; Tsai CH; Tsai FJ; Tsai CH; Huang CY
Oncol Rep; 2013 Dec; 30(6):3027-31. PubMed ID: 24126791
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells.
Han J; Ding L; Yuan B; Yang X; Wang X; Li J; Lu Q; Huang C; Ye Q
Nucleic Acids Res; 2006; 34(10):3095-106. PubMed ID: 16757575
[TBL] [Abstract][Full Text] [Related]
11. Estrogen signalling through amphiregulin may be implicated in human hepatocellular carcinoma.
Carruba G; Miceli V; Cocciadiferro L; Zarcone M; Agostara B; Montalto G; Granata OM
Horm Mol Biol Clin Investig; 2011 Mar; 5(3):153-60. PubMed ID: 25961250
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins.
Tu CC; Kumar VB; Day CH; Kuo WW; Yeh SP; Chen RJ; Liao CR; Chen HY; Tsai FJ; Wu WJ; Huang CY
J Mol Endocrinol; 2013; 51(1):203-12. PubMed ID: 23733894
[TBL] [Abstract][Full Text] [Related]
14. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
16. [Expression of wild type and variant estrogen receptors in human hepatocellular carcinoma].
Xing BC; Wang JH; Wang Y; Hao CY; Huang XF; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):620-2. PubMed ID: 15605095
[TBL] [Abstract][Full Text] [Related]
17. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma.
Villa E; Camellini L; Dugani A; Zucchi F; Grottola A; Merighi A; Buttafoco P; Losi L; Manenti F
Cancer Res; 1995 Feb; 55(3):498-500. PubMed ID: 7834616
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-alpha splice variants in the medial mamillary nucleus of Alzheimer's disease patients: identification of a novel MB1 isoform.
Ishunina TA; Swaab DF; Fischer DF
J Clin Endocrinol Metab; 2005 Jun; 90(6):3757-65. PubMed ID: 15755860
[TBL] [Abstract][Full Text] [Related]
19. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.
Shupnik MA; Pitt LK; Soh AY; Anderson A; Lopes MB; Laws ER
J Clin Endocrinol Metab; 1998 Nov; 83(11):3965-72. PubMed ID: 9814476
[TBL] [Abstract][Full Text] [Related]
20. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
